Provides coverage of remotely connected insulin pens under the pharmacy benefit of medical assistance for eligible patients with diabetes.
Summary
This bill would amend the social services law to require coverage under the Medicaid pharmacy benefit for remotely connected insulin pens for eligible patients with diabetes. The devices covered are insulin pens that can operate interactively and/or autonomously and are intended to be used with prescribed insulin cartridges. The bill specifies that recipients must generally be seven years of age or older, while younger children may use the device under adult supervision.
The measure also directs that the cost of providing this benefit, including administrative costs, be reflected in managed care organization premium payments. In practical terms, it would make these connected insulin delivery devices an available covered service for Medicaid recipients with diabetes, subject to the bill’s age and supervision conditions, and would require the state’s Medicaid financing structure to account for the added expense.
Impact
The bill would add remotely connected insulin pens to the list of covered Medicaid pharmacy-benefit items in section 365-a of the social services law. This would expand state-law coverage obligations for medical assistance and likely affect Medicaid managed care plans, pharmacies, and providers by requiring reimbursement for these devices and associated administration costs. It would also influence how managed care organization premiums are calculated, since the bill requires those costs to be adequately reflected in premium payments.
Sentiment
Based on the bill text and available context, the measure appears to be framed as a health coverage expansion for people with diabetes, with no recorded committee debate or votes indicating opposition or support. The overall sentiment is therefore best characterized as neutral-to-supportive in intent, focused on improving access to diabetes management technology through Medicaid coverage. Because there are no transcripts or vote records provided, there is no documented public controversy in the available materials.
Contention
No specific points of contention are documented in the provided materials. Potential issues that could arise from the bill’s language include the cost of adding a new covered benefit, how managed care premiums would be adjusted, and whether the age-based eligibility and adult-supervision requirement are appropriate or sufficiently clear. However, the record supplied here does not show any named opponents, supporters, or formal objections.
Requires Medicaid coverage for continuous glucose monitors and related supplies for individuals diagnosed with diabetes who meet certain coverage eligibility criteria.
Allows remote patient monitoring of pregnant patients; requires reimbursement for remote patient monitoring rendered to certain Medicaid beneficiaries.